CXCL12/SDF-1 beta Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # AF-351-NAF
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Lys22-Met93
Accession # P48061
Specificity
Clonality
Host
Isotype
Applications for CXCL12/SDF-1 beta Antibody [FITC]
Western Blot
Neutralization
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: CXCL12/SDF-1 beta
CXCL12 is a heparin-binding chemokine that regulates lymphopoiesis, enhances the survival of myeloid progenitor cells, regulates the patterning and cell number of neural progenitors, and promotes angiogenesis. CXCL12/SDF-1 beta is one of several SDF-1 isoforms, all of which can undergo proteolytic processing of the first two N-terminal amino acids by DPPIV/CD26. SDF-1 isoforms signal through CXCR4 and CXCR7 and can also bind Syndecan-4. Their binding to CXCR4 may block the cellular entry of HIV.
Alternate Names
Gene Symbol
Additional CXCL12/SDF-1 beta Products
Product Documents for CXCL12/SDF-1 beta Antibody [FITC]
Product Specific Notices for CXCL12/SDF-1 beta Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.